Wadhwani, N.; Nayak, S.; Wang, Y.; Hashizume, R.; Jie, C.; Mania-Farnell, B.; James, C.D.; Xi, G.; Tomita, T.
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. Cancers 2023, 15, 3429.
https://doi.org/10.3390/cancers15133429
AMA Style
Wadhwani N, Nayak S, Wang Y, Hashizume R, Jie C, Mania-Farnell B, James CD, Xi G, Tomita T.
WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. Cancers. 2023; 15(13):3429.
https://doi.org/10.3390/cancers15133429
Chicago/Turabian Style
Wadhwani, Nitin, Sonali Nayak, Yufen Wang, Rintaro Hashizume, Chunfa Jie, Barbara Mania-Farnell, Charles David James, Guifa Xi, and Tadanori Tomita.
2023. "WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas" Cancers 15, no. 13: 3429.
https://doi.org/10.3390/cancers15133429
APA Style
Wadhwani, N., Nayak, S., Wang, Y., Hashizume, R., Jie, C., Mania-Farnell, B., James, C. D., Xi, G., & Tomita, T.
(2023). WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. Cancers, 15(13), 3429.
https://doi.org/10.3390/cancers15133429